U.S. market Closed. Opens in 16 minutes

PAVM | PAVmed Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for PAVM we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is very wealthy, Growth is very bad and Health is frighteningly weak.

Valuation (38%)

Company Industry
P/E Ratio (TTM) 0.27 35.85
PEG Ratio (TTM) 0.00 -2.98
P/S Ratio (TTM) 1.77 6.46
P/B Ratio (TTM) -1.33 4.58
P/FCF Ratio (TTM) -0.16 45.74
Price to 5YR AVG Earnings Ratio -0.06 62.71
Price to 5YR AVG FCF Ratio -0.18 35.58

Profitability (75%)

Company Industry
ROA (TTM) 79.62% 5.27%
ROE (TTM) -48.30% 25.94%
Net Profit Margin (TTM) 602.98% -0.07%
ROIC 5YR AVG 454.20% 4.06%

Growth (40%)

4QTR AVG 3YR AVG 5YR AVG
EPS 169.85% 4.34% -0.26%
Revenue 6.89% N/A 105.16%
Net Income 184.04% -50.27% -43.07%
Cash Flow 4.35% -67.10% -49.89%

Health (7%)

Company Industry
Current Ratio (TTM) 0.06 2.58
Quick Ratio (TTM) 0.06 1.95
D/E Ratio (TTM) -6.58 -0.03
Interest Coverage (TTM) -960.02 13.09
Piotroski F-Score 3 6
Altman Z-Score N/A 7.10
LTL to 5YR AVG FCF -0.07 3.63
Shares Outstanding Growth 5YR AVG 38.55% 2.34%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙